Krainer Adrian R. 4
4 · Stoke Therapeutics, Inc. · Filed Mar 12, 2026
Research Summary
AI-generated summary of this filing
Stoke Therapeutics (STOK) Director Adrian R. Krainer Sells 33,243 Shares
What Happened Adrian R. Krainer, a director of Stoke Therapeutics, sold 33,243 shares on March 10, 2026. The reported weighted-average sale price was $39.74 per share for total proceeds of $1,320,964. The filing lists the transaction as an open-market or private sale (code S), which is generally a routine insider sale rather than a purchase signal.
Key Details
- Transaction date: March 10, 2026; Form 4 filed March 12, 2026 (appears timely — Form 4s are due within two business days).
- Price: weighted-average $39.74; individual sale prices ranged from $39.50 to $40.11 per share.
- Shares sold: 33,243; reported proceeds: $1,320,964.
- Shares owned after the transaction: not specified in the provided filing excerpt.
- Footnotes: (1) Sale executed under a Rule 10b5-1 trading plan adopted August 15, 2025. (2) Reported price is a weighted average; the filer will provide a per-price breakdown on request.
Context This was a sale executed under a pre-established 10b5-1 plan, which allows insiders to sell according to a preset schedule and is typically viewed as routine. Sales do not necessarily indicate negative company-specific information; purchases are generally more informative about insider sentiment.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-03-10$39.74/sh−33,243$1,320,964→ 283,302 total
Footnotes (2)
- [F1]The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2025.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.11 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.